IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis.
Fassett MS, Braz JM, Castellanos CA, Salvatierra JJ, Sadeghi M, Yu X, Schroeder AW, Caston J, Munoz-Sandoval P, Roy S, et al. Sci Immunol. 2023 Oct 20; 8(88):eabi6887. Epub 2023 Oct 13.